Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2025-12-25 @ 11:20 PM
NCT ID:
NCT01898793
Group ID:
EG004
Title:
Phase II (IL-2): Maximum NK Cell/Number kg
Description:
The recipient will begin a lymphodepleting preparative regimen of fludarabine and cyclophosphamide on Day -6. The haploidentical donor identified by HLA matching of the immediate family members will undergo non-mobilized large volume (20-L) leukapheresis on Day -1, and the NK cell product will be infused into the recipient on Day 0. Subcutaneous IL-2 will begin approximately 2-4 hours after infusion and will continue every other day through Day 12 for a total of 7 doses.
Deaths Number Affected:
9
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
9
Other Number Affected:
9
Other Number At Risk:
9
Study:
NCT01898793
Results Section:
NCT01898793
Adverse Events Module:
NCT01898793